NasdaqGM - Delayed Quote USD

Star Equity Holdings, Inc. (STRR)

0.8799

-0.0102

(-1.15%)

At close: May 17 at 4:00 PM EDT

Key Events

Loading Chart for STRR

9/21 12:03 PM

DELL

Previous Close 0.8901
Open 0.9000
Bid --
Ask --
Day's Range 0.8799 - 0.9100
52 Week Range 0.7500 - 1.5900
Volume 20,653
Avg. Volume 24,164
Market Cap (intraday) 13.945M
Beta (5Y Monthly) 0.23
PE Ratio (TTM) --
EPS (TTM) -0.1200
Earnings Date May 20, 2024
Forward Dividend & Yield --
Ex-Dividend Date Aug 15, 2018
1y Target Est --

Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.

www.starequity.com

171

Full Time Employees

December 31

Fiscal Year Ends

Sector

Diagnostics & Research

Industry

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

STRR

16.20%

S&P 500

11.18%

1-Year Return

STRR

11.38%

S&P 500

29.04%

3-Year Return

STRR

66.03%

S&P 500

27.06%

5-Year Return

STRR

86.46%

S&P 500

84.38%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Star Equity Holdings, Inc.

0.8799

-1.15%

Mkt Cap 13.945M

Industry Diagnostics & Research

Pacific Edge Limited

0.0600

-1.80%

Mkt Cap 48.678M

Industry Diagnostics & Research

Psychemedics Corporation

2.5800

+0.78%

Mkt Cap 14.978M

Industry Diagnostics & Research

Fulgent Genetics, Inc.

20.20

-1.94%

Mkt Cap EUR 604.471M

Industry Diagnostics & Research

OncoCyte Corporation

2.9300

-3.93%

Mkt Cap 39.158M

Industry Diagnostics & Research

6.29

+4.14%

Mkt Cap 9.243M

Industry Diagnostics & Research

1.9300

-9.81%

Mkt Cap 49.776M

Industry Diagnostics & Research

Olink Holding AB (publ)

23.95

0.00%

Mkt Cap 2.978B

Industry Diagnostics & Research

LumiraDx Limited

0.0200

0.00%

Mkt Cap 246.506M

Industry Diagnostics & Research

Telo Genomics Corp.

0.1227

+1.32%

Mkt Cap 9.427M

Industry Diagnostics & Research

Neogen Corporation

13.54

+0.97%

Mkt Cap 2.933B

Industry Diagnostics & Research

Valuation Measures

As of 5/17/2024

Market Cap

13.94M
Enterprise Value

13.38M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

0.30
Price/Book (mrq)

0.30
Enterprise Value/Revenue

0.29
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

54.89%
Return on Assets (ttm)

-3.65%
Return on Equity (ttm)

-3.56%
Revenue (ttm)

45.78M
Net Income Avi to Common (ttm)

-3.82M
Diluted EPS (ttm)

-0.1200

Balance Sheet and Cash Flow

Total Cash (mrq)

23.16M
Total Debt/Equity (mrq)

5.53%
Levered Free Cash Flow (ttm)

1.91M

STRR does not have Company Insights

PRFX PainReform Ltd.

0.8455

+0.77%

AEHL Antelope Enterprise Holdings Limited

1.4027

-2.59%

OLB The OLB Group, Inc.

4.8500

-4.15%

CNFR Conifer Holdings, Inc.

0.8797

+0.01%

AUUD Auddia Inc.

1.4000

-3.45%

LIXT Lixte Biotechnology Holdings, Inc.

2.4604

+2.09%

NUWE Nuwellis, Inc.

0.2590

-5.41%

MDIA MediaCo Holding Inc.

1.3800

-9.21%

CUEN Cuentas Inc.

0.3200

-15.79%

VRPX Virpax Pharmaceuticals, Inc.

0.7810

-1.26%

VERO Venus Concept Inc.

0.6210

-2.66%

NLSP NLS Pharmaceutics Ltd.

0.1640

+9.77%

LEXX Lexaria Bioscience Corp.

3.1500

+0.32%

VINO Gaucho Group Holdings, Inc.

4.3901

+1.39%

TLIS Talis Biomedical Corporation

8.98

+0.34%

IKT Inhibikase Therapeutics, Inc.

1.7300

-1.70%